Navigation Links
US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream
Date:1/6/2009

COMMACK, N.Y., Jan. 6 /PRNewswire/ -- In recent controlled studies conducted by Dr. Richard Bloomer, University of Memphis, scientists found that the patented ingredient in Glyc'n Go(TM), GlycoCarn(R), is the first and only proven ingredient to increase levels of nitric oxide (NO) in the body; thereby increasing blood nitrate/nitrate (NOx) in human subjects.

Nitric oxide acts as a vasodilator and enables an increase in blood flow to the skeletal muscles. This is significant to 1.) increasing oxygen and nutrient delivery for cellular energy production and 2.) removing metabolic wastes such as lactic acid and carbon dioxide. The resulting affect of an NO increase is improved performance and recovery.

Glyc'n Go(TM) is formulated in the USA by LIFEXPAND(TM). The sports supplement assists in shuttling fatty acids into the cell's mitochondria, enhancing ATP energy production. In addition to the NO and energy benefits; Glyc'n Go(TM) provides antioxidant functions by diminishing the potentially harmful effects of free radicals and aiding in the reduction of muscle tissue damage due to lactic acid build up.

Glyc'n Go(TM) delivers more pure GlycoCarn(R) per serving than any other GPLC tablet or capsule on the market today. Glyc'n Go(TM) is the only chewable form of GlycoCarn(R) and has been proven to dissolve 26% faster than tablets, enabling the product to enter the blood stream and take effect with maximum efficiency.

Glyc'n Go(TM) addresses the needs of many athletes, from strength and power, to endurance and speed. The multitude of benefits offer a number of uses to the active human body.

Glyc'n Go(TM) is manufactured in the USA by LIFEXPAND(TM), Inc. As a service and commitment to the athletic community, LIFEXPAND(TM) rigorously tests it products, including Glyc'n Go(TM), under strict protocols. Glyc'n Go(TM) is certified banned-substance free by Informed-Choice(TM) and HFL, the world's largest sports regulatory and research lab.

Glyc'n Go(TM) is available from leading supplement retailers in 60 count and 16-count individual serving packets. For more detailed information visit www.glycngo.com or call toll free 1-877-GLYCNGO.

Hi resolution photos and images are available at http://www.creativeimage.com/glycngopress


'/>"/>
SOURCE LIFEXPAND
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. California Legislature Passes Historic HIV Testing Bill (AB 682); AHF Urges Governor to Sign Crucial Lifesaving Legislation
2. Intellect Neurosciences, Inc. and CHDI, Inc. Enter Into Compound Testing Agreement to Evaluate OXIGON(TM) as a Potential Treatment for Huntington Disease
3. Signalife Completes Testing of Modules for Holter and Intra-Cardiac Monitor
4. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
5. Facet Solutions AFRS(TM) Demonstrates Biomechanical Advantages Over Dynamic Stabilization in Independent Testing
6. Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
7. Test for Life Commends North Carolina Rules Commission for Implementing CDC Recommendations for HIV Testing
8. Congressional Funds Awarded for Testing of Antimicrobial Copper Metals
9. Aida Announces Completion of Anti-Cancer Drug Phase Two Testing
10. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
11. iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... 2016 Research and Markets has announced ... report to their offering. ... The report forecasts the global optical transceiver market to ... The report covers the present scenario and the growth ... the market size, the report considers the revenue generated from the ...
(Date:12/9/2016)... Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company engaged ... rare diseases, today announced that senior management will participate in a ... at the InterContinental Barclay Hotel in New York City ... About aTyr Pharma ... aTyr Pharma is engaged in the discovery ...
(Date:12/9/2016)... 2016  Axovant Sciences Ltd. (NYSE: ... on the treatment of dementia, today announced a ... 2b trial evaluating treatment with intepirdine (RVT-101), combined ... plus placebo in people with mild-to-moderate Alzheimer,s disease. ... to treatment was associated with reduced progression in ...
Breaking Medicine Technology:
(Date:12/9/2016)... Harrisburg, PA (PRWEB) , ... December 09, 2016 ... ... concussion education program through the Pennsylvania Cable Network (PCN) during the summer of ... Brain Injury Implementation Grant provided by the United States Department of Health and ...
(Date:12/8/2016)... Pennsylvania (PRWEB) , ... December 08, 2016 , ... ... Duck Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which ... , “This was our first franchise-wide Quack Gives Back initiative, ...
(Date:12/8/2016)... , ... December 08, 2016 , ... CURE Media Group, ... and advocacy groups, has aligned with Upstage Lung Cancer in efforts to combat lung ... announcement, Michael J. Hennessy, Jr said, “CURE Media Group is honored to team up ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView Software aims ... employees that are both engaging and easy to use. Coming off the heels ... company revealed today its plans to roll out new AI-powered self-service enhancements to ...
(Date:12/8/2016)... Dallas, TX (PRWEB) , ... December 08, 2016 , ... ... to continue to be a convenient service for Texas, they are expanding their presence ... will involve a hiring spree that will bring new jobs to the Dallas and ...
Breaking Medicine News(10 mins):